The pathogenesis of the bone disease of multiple myeloma
- 30 June 2008
- journal article
- review article
- Published by Elsevier BV in Bone
- Vol. 42 (6), 1007-1013
- https://doi.org/10.1016/j.bone.2008.01.027
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- Myeloma Cell-Osteoclast Interaction Enhances Angiogenesis Together with Bone Resorption: A Role for Vascular Endothelial Cell Growth Factor and OsteopontinClinical Cancer Research, 2007
- Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)–dependent migration and homing in multiple myelomaBlood, 2006
- Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivoBlood, 2006
- Proteasome inhibitors abrogate osteoclast differentiation and osteoclast functionBiochemical and Biophysical Research Communications, 2005
- Anti-α4 integrin antibody suppresses the development of multiple myeloma and associated osteoclastic osteolysisBlood, 2004
- Stromal Cell-Derived Factor-1 (SDF-1) Recruits Osteoclast Precursors by Inducing Chemotaxis, Matrix Metalloproteinase-9 (MMP-9) Activity, and Collagen TransmigrationJournal of Bone and Mineral Research, 2003
- Vascular Endothelial Growth Factor Can Substitute for Macrophage Colony-Stimulating Factor in the Support of Osteoclastic Bone ResorptionThe Journal of Experimental Medicine, 1999
- Myeloma bone diseaseEuropean Journal of Cancer, 1998
- Bone marrow angiogenesis and progression in multiple myelomaBritish Journal of Haematology, 1994
- Production of Lymphotoxin, a Bone-Resorbing Cytokine, by Cultured Human Myeloma CellsNew England Journal of Medicine, 1987